Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6137
Source ID: NCT00888719
Associated Drug: Cwp-0403 100mg
Title: Therapeutic Exploratory Study of CWP-0403
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: CWP-0403 100mg|DRUG: placebo|DRUG: CWP-0403 50mg
Outcome Measures: Primary: Change in HbA1c before and after treatment, 12 weeks | Secondary: HbA1c target achievement rate(Ratio of the patients with HbA1c lower than 6.5% or 7%), 12 weeks|Fasting blood glucose level change and rate of change, 12 weeks|Serum insulin, serum C-peptide level change, 12 weeks|HOMA-R and HOMA-β change rate, 12 weeks|Triglyceride, LDL-cholesterol and HDL-cholesterol change, 12 weeks
Sponsor/Collaborators: Sponsor: JW Pharmaceutical
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 145
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2009-02
Completion Date: 2010-04
Results First Posted:
Last Update Posted: 2010-11-05
Locations: Chonbuk National University Hospital, Seoul, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of|Gachon Medical School Gil Medical Center, Seoul, Korea, Republic of|Inha University Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Kyungpook National University Hospital, Seoul, Korea, Republic of|Seoul National University Bundang Hopital, Seoul, Korea, Republic of|The Catholic University of Korea, Holly Family Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Seoul, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT00888719

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress